Skip to content

Our responsibility

Our commitments

We are committed to acting as a responsible global citizen and supporting the United Nations' 17 Sustainable Development Goals (SDGs). We participate actively in selected ESG and sustainability fora and partner with organizations that share our objective of combating global warming and promoting responsible research, business and medicine production.




A United Nations pact to encourage companies worldwide to adopt sustainable and socially responsible policies and to report on their implementation of the Ten Principles of the UN Global Compact. LEO Pharma has been a signatory of UN Global Compact since 2018


Champions science-based target setting as a powerful way of boosting organizations’ competitive advantage in the transition to the low-carbon economy. It is a collaboration between the Carbon Disclosure Project (CDP), World Resources Institute (WRI), the World Wide Fund for Nature (WWF) and the United Nations Global Compact (UNGC). LEO Pharma had its emissions reduction targets validated by SBTi in 2022


The company-signatories of this declaration share common values and believe that the welfare of animals used in the research and production of medicines and vaccines requires the greatest consideration. This work demands application of high and most consistent standards of animal welfare and laboratory animal science regardless of where it is performed. LEO Pharma became a signatory of the Marseille Declaration in 2022


Announced in 2021, LEO Pharma's Diversity, Equity & Inclusion manifesto, Curiosity Beyond, encourages LEO Pharma's employees to embrace their differences and explore beyond the obvious. In 2024, LEO Pharma will conduct a Double Materiality Assessment in preparation for the new Corporate Sustainability Reporting Directive (CSRD). In 2026, LEO Pharma will be required to meet CSRD requirements in its annual report (reflecting results for the fiscal year 2025).